NEOG Form 4: 2,071 RSUs Converted to Shares for Director
Rhea-AI Filing Summary
Catherine E. Woteki, a director of NEOGEN CORP (NEOG), had 2,071 restricted stock units vest and be settled into 2,071 shares of common stock on 10/07/2025. The RSUs were settled at a reported per-share value of $5.63, and following the transaction the reporting person beneficially owned 15,315 shares.
The filing is a routine Section 16 Form 4 reporting the vesting and settlement of equity compensation; it shows an increase in the director’s direct holdings but does not disclose any cash sale or purchase beyond the RSU settlement.
Positive
- 2,071 RSUs vested and were settled, converting compensation into direct equity
- Beneficial ownership increased to 15,315 shares, strengthening director alignment with shareholders
Negative
- None.
Insights
Director equity compensation vested into 2,071 shares on 10/07/2025.
The vesting and settlement of restricted stock units converts once‑subject-to‑restrictions equity into immediately owned common stock, increasing the director's direct holdings to 15,315 shares. This is a routine compensation event that aligns the director's economic interest with shareholders.
The main dependencies are timing of vesting schedules and any post‑vesting sales not reported here; investors can watch for subsequent Form 4 filings if shares are later sold within the short term.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 2,071 | $5.63 | $12K |
| Exercise | Common Stock | 2,071 | $5.63 | $12K |
FAQ
What did NEOG director Catherine Woteki report on Form 4 (NEOG)?
At what price were the RSUs settled for NEOG (NEOG)?
Who filed the Form 4 for NEOG (NEOG) on behalf of the reporting person?
How can investors monitor further insider activity for NEOG (NEOG)?
AI-generated analysis. How Rhea-AI works. Not financial advice.